The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.

The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...

Headquartered in North St. Louis County, Express Scripts, a subsidiary of The Cigna Group, is demanding the FTC retract a ...

Cigna Group’s Express Scripts sued the US Federal Trade Commission over a recent report that the company said demonizes ...

The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.

Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...

The FTC has taken unconstitutional actions in publishing a report that ignores the evidence provided by our company and other ...

Express Scripts is demanding the FTC retract its report, claiming it's filled with "false and misleading claims." ...